Delivery Order SPE2DB25D3110-SPE2DB25FTELP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,946.09 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,918.21 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed price contract, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, represents a competitively awarded non-set-aside delivery order. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,223.68 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count package). This firm fixed price delivery order, which represents a non-competitive set-aside award, is scheduled for completion by September 19, 2025, with performance based in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Yuvafem 10 MCG vaginal inserts (18-count units) with a ceiling value of $3,966.96. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and requires completion by September 3, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete procurement action...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Yuvafem 10 mcg vaginal insert (18 units) under a firm fixed-price contract valued at $1,396.56. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value...
- The Defense Logistics Agency awarded a delivery order valued at $4,543.33 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count) on September 25, 2025, with a completion date of September 26, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,197.71 to AmerisourceBergen Drug Corp on August 11, 2025, for Yuvafem 10 mcg vaginal inserts (18-count). This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,145.73 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18-count) on August 13, 2025, with completion scheduled for August 14, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, procured through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,607.76 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract, classified as a non-set-aside award, will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count units) at a firm fixed price of $1,477.02. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTELPDelivery Order
The Defense Logistics Agency awarded a $3,426.72 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Yuvafem 10 micrograms vaginal inserts (18 units). This is a firm fixed-price contract with a completion date of September 23, 2025, and represents a non-competitive set-aside delivery against a larger contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceuticals, medical devices, vaccines, and specialty healthcare commodities to support military and federal healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of competitively awarded, non-set-aside contracts demonstrates its established capability to meet federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/22/25 |